If organizations are using novel methods like AI and machine learning for HEOR studies or other use cases, they also need to govern those outcomes and the performance of those models,” said Sherrine Eid, Global Head of Real-World Evidence and Epidemiology at SAS Institute. “Without regulation, you’re talking about an industry that will be asked to self-regulate. And there are critical downstream impacts if governance doesn’t get the attention it deserves.